Work

Abstract PS5-05-08: Physician perspectives on treatment decision-making process in high-risk early-stage triple negative breast cancer (esTNBC) in a community oncology setting

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps5-05-08

Authors: A. Haiderali, L. Okoth, S. Annavarapu, J. K. Paulus, W. Pan, P. Conkling, M. Danso

Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), Virginia Oncology Associates

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129521120

Cites:

Cited by:

Related to: